100 likes | 208 Vues
Explore the status of misting systems in urban areas, addressing concerns like exposure risks and enforcement issues. Learn about the ongoing initiatives, proposed labeling, and remaining challenges. Consider next steps for industry collaboration and regulatory decisions.
E N D
Status of Urban Misting SystemsWhat Next? Jim Roelofs Field and External Affairs Division Office of pesticide Programs
Background • SFIREG Issue Paper: • Disallow residential use, OR • Ensure label directions for it • Concerns include -- unwanted exposure to people &nontargets; lack of data for risk assessment; efficacy and resistance issues; enforcement problems; and more
Background, cont. • OPP action item since 2005 • Fall 2005, NPMA proposes stakeholder forum • Forum held December 2005 – broad participation; many issues discussed
The Ad Hoc Group • Outcome of forum – ad hoc group to take on 3 tasks: • Label recommendations for pyrethrins, PBO, permethrin: REDS coming soon • “BMPs” for industry • Research project on exposure and efficacy • NPMA, industry, FL & NM, AMCA – not OPP
Status: Ad hoc group • Sent label recommendations to SRRD • Rough draft protocol for research project • “BMP” project still not yet active (waiting for REDs?)
Status: the REDs • Permethrin done; pyrethrins, PBO delayed – probable release = mid-June • Contain label language for misters; and require more exposure related data • 60 day comment period
Proposed labeling includes: • Must affirm or prohibit use in misters • Precautions – people, pets, food, pools and water bodies • Application quantity/rate limitation • Consumer gets the label • Reservoir tanks have content label
Remaining issues • Most of them – adequate data for assessment; enforcement issues (who is the applicator?) is this allowable distribution or not? Etc. • Main issue is that the 2(ee) door is still open for any pesticide other than py, PBO and permethrin
Next Steps • Brief OPP Steering Committee – 5/22 • Choose next steps now – or – wait for final REDs decisions (after comment period)? • What do you suggest???
Some options • Develop public outreach – fact sheet/Q and A • Collaborate with NPMA on industry guidance • Develop generic policy – PRN? Rule?